php // dynamic_sidebar( 'budget-banner-widget' );
?>
php // }
?>
-
Investors will continue to monitor India's Covid situation as the country continues to battle a second wave that is pushing its healthcare system to the brink
-
"SIP is the best way for investors to beat the market volatility," he said
-
Pharma sector saw profit booking as Nifty Pharma index lost 0.87%.
-
Vedanta rose 3.84% to Rs 236.60 on reports that the Tamil Nadu government has allowed the company's Sterlite Industries plant in Tuticorin, Tamil Nadu to produce oxygen for four months.
-
With an investment of over Rs 16,000 crore in equities, Jhunjhunwala is the second-biggest individual investor in the country after D-Mart owner Radhakishan Damani
-
In August 2020, shares of the company got suspended by the bourses for not complying with listing norms pertaining to the submission of quarterly financial results
-
The demand for oxygen is likely to remain high as long due to the Covid-19 situation in the country
-
Total COVID-19 confirmed cases worldwide stood at 146,830,782 with 31,06,384 deaths.
-
Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of COVID-19 positive patients.
-
The 14th season of the league, like in the past, has thrills, adventures, disappointments and some lessons for the equity investors